Ethical issues in managing the COVID-19 pandemic
The COVID-19 pandemic has had an immense and worldwide impact. In light of future pandemics or subsequent waves of COVID-19 it is crucial to focus on the ethical issues that were and still are raised in this COVID-19 crisis. In this paper, we look at issues that are raised in the testing and tracing...
| Autores principales: | ; ; |
|---|---|
| Tipo de documento: | Electrónico Artículo |
| Lenguaje: | Inglés |
| Verificar disponibilidad: | HBZ Gateway |
| Journals Online & Print: | Gargar...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Publicado: |
Wiley-Blackwell
2021
|
| En: |
Bioethics
Año: 2021, Volumen: 35, Número: 6, Páginas: 581-588 |
| Clasificaciones IxTheo: | NCA Ética NCC Ética social NCH Ética de la medicina TK Período contemporáneo |
| Otras palabras clave: | B
allocation of scarce goods
B SARS-CoV-2 B Proportionality B Covid-19 B contact tracing |
| Acceso en línea: |
Volltext (kostenfrei) Volltext (kostenfrei) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1764871715 | ||
| 003 | DE-627 | ||
| 005 | 20211006155858.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210729s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12877 |2 doi | |
| 035 | |a (DE-627)1764871715 | ||
| 035 | |a (DE-599)KXP1764871715 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Raus, Kasper |e VerfasserIn |0 (orcid)0000-0002-1281-0022 |4 aut | |
| 245 | 1 | 0 | |a Ethical issues in managing the COVID-19 pandemic |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a The COVID-19 pandemic has had an immense and worldwide impact. In light of future pandemics or subsequent waves of COVID-19 it is crucial to focus on the ethical issues that were and still are raised in this COVID-19 crisis. In this paper, we look at issues that are raised in the testing and tracing of patients with COVID-19. We do this by highlighting and expanding on an approach suggested by Fineberg that could serve as a public health approach. In this way, we highlight several ethical issues. As regards testing, questions are raised such as whether it is ethical to use less reliable tests in order to increase testing capacity or minimize harm for patients. Another issue is how wide testing should be and whether selective testing is in accordance with principles of social justice. Patients who have recovered from COVID-19 might have some degree of immunity but attributing certain ‘immunopriviliges’ raises ethical questions. The use of various tracing methodologies (mobile apps or databases and trained tracers) raised evident questions of social justice and privacy. We argue why it is key to always uphold a test of proportionality where a fair balance must be sought. | ||
| 601 | |a COVID-19 | ||
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a Proportionality | |
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a contact tracing | |
| 650 | 4 | |a allocation of scarce goods | |
| 652 | |a NCA:NCC:NCH:TK | ||
| 700 | 1 | |a Mortier, Eric |e VerfasserIn |4 aut | |
| 700 | 1 | |a Eeckloo, Kristof |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 35(2021), 6, Seite 581-588 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:6 |g pages:581-588 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12877 |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via crossref license)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.12877 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12877 |x Verlag |z kostenfrei |3 Volltext |
| 935 | |a mteo | ||
| 936 | u | w | |d 35 |j 2021 |e 6 |h 581-588 |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 3958392717 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1764871715 | ||
| LOK | |0 005 20220127114729 | ||
| LOK | |0 008 210729||||||||||||||||ger||||||| | ||
| LOK | |0 035 |a (DE-Tue135)IxTheo#2021-07-28#106F3D36474323053B88FAC63BB537A82E6074CF | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a zota | ||
| LOK | |0 936ln |0 1442053887 |a TK | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| LOK | |0 936ln |0 144205283X |a NCC | ||
| LOK | |0 936ln |0 1442052465 |a NCA | ||
| OAS | |a 1 | ||
| ORI | |a SA-MARC-ixtheoa001.raw | ||
| REL | |a 1 | ||
| STA | 0 | 0 | |a Severe acute respiratory syndrome-related coronavirus 2 |
| STB | 0 | 0 | |a SARS-CoV-2 (virus) |
| STC | 0 | 0 | |a SARS-CoV-2 |
| STD | 0 | 0 | |a SARS-CoV-2,SARS-CoV-2 |
| STF | 0 | 0 | |a 嚴重急性呼吸綜合症冠狀病毒2型 |
| STG | 0 | 0 | |a Coronavírus da síndrome respiratória aguda grave 2 |
| STH | 0 | 0 | |a SARS-CoV-2 |
| STI | 0 | 0 | |a SARS-CoV-2 |
| SUB | |a REL | ||
| SYE | 0 | 0 | |a Schweres akutes Atemwegssyndrom Coronavirus 2,Severe acute respiratory syndrome coronavirus 2,2019-nCoV,2019-novel Corona virus,Wuhan-Coronavirus |